An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors
| Autor: | Ychou, M. *, Conroy, T., Seitz, J.F., Gourgou, S., Hua, A., Mery-Mignard, D., Kramar, A. |
|---|---|
| Zdroj: | In Annals of Oncology March 2003 14(3):481-489 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|